Labeler
Sumitomo Pharma America, Inc. NDC Codes
Sumitomo Pharma America, Inc. lists 14 finished drug products in the FDA NDC Directory under NDC labeler codes 63402, 72359, 72974, 73336.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Active ingredients
- Lurasidone hydrochloride, Eslicarbazepine acetate, Relugolix, Allogeneic thymocyte-depleted thymus tissue-agdc, Estradiol hemihydrate, Norethindrone acetate, Vibegron
- NDC labeler codes
- 63402, 72359, 72974, 73336
- Strengths
- Allogeneic thymocyte-depleted thymus tissue-agdc 22000 mm/1; Relugolix 40 mg/1; Estradiol hemihydrate 1 mg/1; Norethindrone acetate .5 mg/1; Vibegron 75 mg/1; Relugolix 120 mg/1; Eslicarbazepine acetate 200 mg/1; Eslicarbazepine acetate 400 mg/1; Eslicarbazepine acetate 600 mg/1; Eslicarbazepine acetate 800 mg/1; Lurasidone hydrochloride 60 mg/1; Lurasidone hydrochloride 120 mg/1; Lurasidone hydrochloride 20 mg/1; Lurasidone hydrochloride 40 mg/1; Lurasidone hydrochloride 80 mg/1
- Dosage forms
- Tablet, Film coated, Tablet, Implant, Kit
- Routes
- Oral, Intramuscular
- Drug classes (FDA established)
- Atypical Antipsychotic, Gonadotropin Releasing Hormone Receptor Antagonist, Estrogen, Progestin, beta3-Adrenergic Agonist
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 43
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Rethymicallogenic thymocyte-depleted thymus tissue-agdc | Allogeneic thymocyte-depleted thymus tissue-agdc 22000 mm/1 | ImplantIntramuscular | 72359-001 | 72359-0001-01 | — |
| Myfembreerelugolix, estradiol hemihydrate, and norethindrone acetate | Relugolix 40 mg/1 + 2 more ingredients | Tablet, Film coatedOral | 72974-415 | 72974-0415-0172974-0415-99 | — |
| Gemtesavibegron | Vibegron 75 mg/1 | Tablet, Film coatedOral | 73336-075 | 73336-0075-0773336-0075-3073336-0075-90 | — |
| Orgovyxrelugolix | Relugolix 120 mg/1 | Tablet, Film coatedOral | 72974-120 | 72974-0120-0172974-0120-9572974-0120-97 | — |
| Aptiomeslicarbazepine acetate | Eslicarbazepine acetate 200 mg/1 | TabletOral | 63402-202 | 63402-0202-2863402-0202-30 | — |
| Aptiomeslicarbazepine acetate | Eslicarbazepine acetate 400 mg/1 | TabletOral | 63402-204 | 63402-0204-2863402-0204-30 | — |
| Aptiomeslicarbazepine acetate | Eslicarbazepine acetate 600 mg/1 | TabletOral | 63402-206 | 63402-0206-2863402-0206-60 | — |
| Aptiomeslicarbazepine acetate | Eslicarbazepine acetate 800 mg/1 | TabletOral | 63402-208 | 63402-0208-2863402-0208-30 | — |
| Aptiomeslicarbazepine acetate | — | KitOral | 63402-248 | 63402-0248-56 | — |
| Latudalurasidone hydrochloride | Lurasidone hydrochloride 60 mg/1 | Tablet, Film coatedOral | 63402-306 | 63402-0306-0463402-0306-1063402-0306-30+2 more | — |
| Latudalurasidone hydrochloride | Lurasidone hydrochloride 120 mg/1 | Tablet, Film coatedOral | 63402-312 | 63402-0312-0463402-0312-1063402-0312-30+2 more | — |
| Latudalurasidone hydrochloride | Lurasidone hydrochloride 20 mg/1 | Tablet, Film coatedOral | 63402-302 | 63402-0302-0463402-0302-1063402-0302-30+2 more | — |
| Latudalurasidone hydrochloride | Lurasidone hydrochloride 40 mg/1 | Tablet, Film coatedOral | 63402-304 | 63402-0304-0463402-0304-1063402-0304-30+2 more | — |
| Latudalurasidone hydrochloride | Lurasidone hydrochloride 80 mg/1 | Tablet, Film coatedOral | 63402-308 | 63402-0308-0463402-0308-1063402-0308-30+2 more | — |
Sumitomo Pharma America, Inc.: common questions
- What is Sumitomo Pharma America, Inc.'s NDC labeler code?
- 63402, 72359, 72974, 73336. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Sumitomo Pharma America, Inc.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.